|
1
|
Ursell LK, Metcalf JL, Parfrey LW and
Knight R: Defining the human microbiome. Nutr Rev. 70 (Suppl
1):S38–S44. 2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhang YJ, Li S, Gan RY, Zhou T, Xu DP and
Li HB: Impacts of gut bacteria on human health and diseases. Int J
Mol Sci. 16:7493–7519. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Feng Q, Chen WD and Wang YD: Gut
Microbiota: An Integral Moderator in Health and Disease. Front
Microbiol. 9(151)2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lynch SV and Pedersen O: The Human
Intestinal Microbiome in Health and Disease. N Engl J Med.
375:2369–2379. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Greenhalgh K, Meyer KM, Aagaard KM and
Wilmes P: The human gut microbiome in health: Establishment and
resilience of microbiota over a lifetime. Environ Microbiol.
18:2103–2116. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Neuman H, Debelius JW, Knight R and Koren
O: Microbial endocrinology: The interplay between the microbiota
and the endocrine system. FEMS Microbiol Rev. 39:509–521.
2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ceranowicz P, Warzecha Z and Dembinski A:
Peptidyl hormones of endocrine cells origin in the gut--their
discovery and physiological relevance. J Physiol Pharmacol.
66:11–27. 2015.PubMed/NCBI
|
|
8
|
Sandrini S, Aldriwesh M, Alruways M and
Freestone P: Microbial endocrinology: Host-bacteria communication
within the gut microbiome. J Endocrinol. 225:R21–R34.
2015.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ravussin Y, Koren O, Spor A, LeDuc C,
Gutman R, Stombaugh J, Knight R, Ley RE and Leibel RL: Responses of
gut microbiota to diet composition and weight loss in lean and
obese mice. Obesity (Silver Spring). 20:738–747. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Queipo-Ortuño MI, Seoane LM, Murri M,
Pardo M, Gomez-Zumaquero JM, Cardona F, Casanueva F and Tinahones
FJ: Gut microbiota composition in male rat models under different
nutritional status and physical activity and its association with
serum leptin and ghrelin levels. PLoS One. 8(e65465)2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Gensollen T, Iyer SS, Kasper DL and
Blumberg RS: How colonization by microbiota in early life shapes
the immune system. Science. 352:539–544. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Schmidt TSB, Raes J and Bork P: The Human
Gut Microbiome: From Association to Modulation. Cell.
172:1198–1215. 2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Bultman SJ: Emerging roles of the
microbiome in cancer. Carcinogenesis. 35:249–255. 2014.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Cani PD: Human gut microbiome: Hopes,
threats and promises. Gut. 67:1716–1725. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Mohajeri MH, Brummer RJM, Rastall RA,
Weersma RK, Harmsen HJM, Faas M and Eggersdorfer M: The role of the
microbiome for human health: From basic science to clinical
applications. Eur J Nutr. 57 (Suppl 1):1–14. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Fukui H, Xu X and Miwa H: Role of Gut
Microbiota-Gut Hormone Axis in the Pathophysiology of Functional
Gastrointestinal Disorders. J Neurogastroenterol Motil. 24:367–386.
2018.PubMed/NCBI View
Article : Google Scholar
|
|
17
|
Clarke G, Stilling RM, Kennedy PJ, Stanton
C, Cryan JF and Dinan TG: Minireview: Gut microbiota: the neglected
endocrine organ. Mol Endocrinol. 28:1221–1238. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Vaishnava S, Behrendt CL, Ismail AS,
Eckmann L and Hooper LV: Paneth cells directly sense gut commensals
and maintain homeostasis at the intestinal host-microbial
interface. Proc Natl Acad Sci USA. 105:20858–20863. 2008.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Belkaid Y and Naik S: Compartmentalized
and systemic control of tissue immunity by commensals. Nat Immunol.
14:646–653. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Magnúsdóttir S, Ravcheev D, de
Crécy-Lagard V and Thiele I: Systematic genome assessment of
B-vitamin biosynthesis suggests co-operation among gut microbes.
Front Genet. 6(148)2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Carding S, Verbeke K, Vipond DT, Corfe BM
and Owen LJ: Dysbiosis of the gut microbiota in disease. Microb
Ecol Health Dis. 26(26191)2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Grice EA and Segre JA: The human
microbiome: Our second genome. Annu Rev Genomics Hum Genet.
13:151–170. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Geva-Zatorsky N, Sefik E, Kua L, Pasman L,
Tan TG Ortiz-Lopez A, Yanortsang TB, Yang L, Jupp R, Mathis D, et
al: Mining the Human Gut Microbiota for Immunomodulatory Organisms.
Cell. 168:928–943.e11. 2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Haber AL, Biton M, Rogel N, Herbst RH,
Shekhar K, Smillie C, Burgin G, Delorey TM, Howitt MR, Katz Y, et
al: A single-cell survey of the small intestinal epithelium.
Nature. 551:333–339. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Nash AK, Auchtung TA, Wong MC, Smith DP,
Gesell JR, Ross MC, Stewart CJ, Metcalf GA, Muzny DM, Gibbs RA, et
al: The gut mycobiome of the Human Microbiome Project healthy
cohort. Microbiome. 5(153)2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lloyd-Price J, Mahurkar A, Rahnavard G,
Crabtree J, Orvis J, Hall AB, Brady A, Creasy HH, McCracken C,
Giglio MG, et al: Strains, functions and dynamics in the expanded
Human Microbiome Project. Nature. 550:61–66. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Rothschild D, Weissbrod O, Barkan E,
Kurilshikov A, Korem T, Zeevi D, Costea PI, Godneva A, Kalka IN,
Bar N, et al: Environment dominates over host genetics in shaping
human gut microbiota. Nature. 555:210–215. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Korem T, Zeevi D, Suez J, Weinberger A,
Avnit-Sagi T, Pompan-Lotan M, Matot E, Jona G, Harmelin A, Cohen N,
et al: Growth dynamics of gut microbiota in health and disease
inferred from single metagenomic samples. Science. 349:1101–1106.
2015.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lloyd-Price J, Abu-Ali G and Huttenhower
C: The healthy human microbiome. Genome Med. 8(51)2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hill C, Guarner F, Reid G, Gibson GR,
Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S,
et al: Expert consensus document. The International Scientific
Association for Probiotics and Prebiotics consensus statement on
the scope and appropriate use of the term probiotic. Nat Rev
Gastroenterol Hepatol. 11:506–514. 2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Pandey KR, Naik SR and Vakil BV:
Probiotics, prebiotics and synbiotics- a review. J Food Sci
Technol. 52:7577–7587. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Tsai YL, Lin TL, Chang CJ, Wu TR, Lai WF,
Lu CC and Lai HC: Probiotics, prebiotics and amelioration of
diseases. J Biomed Sci. 26(3)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Goodman B and Gardner H: The microbiome
and cancer. J Pathol. 244:667–676. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Tomasetti C and Vogelstein B: Cancer
etiology. Variation in cancer risk among tissues can be explained
by the number of stem cell divisions. Science. 347:78–81.
2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Ashford NA, Bauman P, Brown HS, Clapp RW,
Finkel AM, Gee D, Hattis DB, Martuzzi M, Sasco AJ and Sass JB:
Cancer risk: Role of environment. Science. 347(727)2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Polo A, Crispo A, Cerino P, Falzone L,
Candido S, Giudice A, De Petro G, Ciliberto G, Montella M, Budillon
A, et al: Environment and bladder cancer: Molecular analysis by
interaction networks. Oncotarget. 8:65240–65252. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Falzone L, Marconi A, Loreto C, Franco S,
Spandidos DA and Libra M: Occupational exposure to carcinogens:
Benzene, pesticides and fibers (Review). Mol Med Rep. 14:4467–4474.
2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Anand P, Kunnumakkara AB, Sundaram C,
Harikumar KB, Tharakan ST, Lai OS, Sung B and Aggarwal BB: Cancer
is a preventable disease that requires major lifestyle changes.
Pharm Res. 25:2097–2116. 2008.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Global Burden of Disease Cancer
Collaboration, Fitzmaurice C, Allen C, Barber RM, Barregard L,
Bhutta ZA, Brenner H, Dicker DJ, Chimed-Orchir O, Dandona R, et al:
Global, Regional, and National Cancer Incidence, Mortality, Years
of Life Lost, Years Lived With Disability, and Disability-Adjusted
Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic
Analysis for the Global Burden of Disease Study. JAMA Oncol.
3:524–548. 2017.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wang H, Naghavi M, Allen C, Barber RM,
Bhutta ZA, Carter A, Casey DC, Charlson FJ, Chen AZ, Coates MM, et
al: GBD 2015 Mortality and Causes of Death Collaborators: Global,
regional, and national life expectancy, all-cause mortality, and
cause-specific mortality for 249 causes of death, 1980-2015: A
systematic analysis for the Global Burden of Disease Study 2015.
Lancet. 388:1459–1544. 2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Rapisarda V, Salemi R, Marconi A, Loreto
C, Graziano AC, Cardile V, Basile MS, Candido S, Falzone L,
Spandidos DA, et al: Fluoro-edenite induces fibulin-3
overexpression in non-malignant human mesothelial cells. Oncol
Lett. 12:3363–3367. 2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Rapisarda V, Ledda C, Matera S, Fago L,
Arrabito G, Falzone L, Marconi A, Libra M and Loreto C: Absence of
t(14;18) chromosome translocation in agricultural workers after
short-term exposure to pesticides. Mol Med Rep. 15:3379–3382.
2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Fenga C, Gangemi S, Di Salvatore V,
Falzone L and Libra M: Immunological effects of occupational
exposure to lead (Review). Mol Med Rep. 15:3355–3360.
2017.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Vogelstein B, Papadopoulos N, Velculescu
VE, Zhou S, Diaz LA Jr and Kinzler KW: Cancer genome landscapes.
Science. 339:1546–1558. 2013.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Guarneri C, Bevelacqua V, Polesel J,
Falzone L, Cannavò PS, Spandidos DA, Malaponte G and Libra M: NF-κB
inhibition is associated with OPN/MMP-9 downregulation in cutaneous
melanoma. Oncol Rep. 37:737–746. 2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Salemi R, Falzone L, Madonna G, Polesel J,
Cinà D, Mallardo D, Ascierto PA, Libra M and Candido S: MMP-9 as a
Candidate Marker of Response to BRAF Inhibitors in Melanoma
Patients With BRAFV600E Mutation Detected in Circulating-Free DNA.
Front Pharmacol. 9(856)2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Leonardi GC, Falzone L, Salemi R, Zanghì
A, Spandidos DA, Mccubrey JA, Candido S and Libra M: Cutaneous
melanoma: From pathogenesis to therapy (Review). Int J Oncol.
52:1071–1080. 2018.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Bhang HE, Ruddy DA, Krishnamurthy
Radhakrishna V, Caushi JX, Zhao R, Hims MM, Singh AP, Kao I, Rakiec
D, Shaw P, et al: Studying clonal dynamics in response to cancer
therapy using high-complexity barcoding. Nat Med. 21:440–448.
2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Kloor M and von Knebel Doeberitz M: The
Immune Biology of Microsatellite-Unstable Cancer. Trends Cancer.
2:121–133. 2016.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Carter SL, Eklund AC, Kohane IS, Harris LN
and Szallasi Z: A signature of chromosomal instability inferred
from gene expression profiles predicts clinical outcome in multiple
human cancers. Nat Genet. 38:1043–1048. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
51
|
Dagogo-Jack I and Shaw AT: Tumour
heterogeneity and resistance to cancer therapies. Nat Rev Clin
Oncol. 15:81–94. 2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Falzone L, Romano GL, Salemi R, Bucolo C,
Tomasello B, Lupo G, Anfuso CD, Spandidos DA, Libra M and Candido
S: Prognostic significance of deregulated microRNAs in uveal
melanomas. Mol Med Rep. 19:2599–2610. 2019.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Battaglia R, Palini S, Vento ME, La
Ferlita A, Lo Faro MJ, Caroppo E, Borzì P, Falzone L, Barbagallo D,
Ragusa M, et al: Identification of extracellular vesicles and
characterization of miRNA expression profiles in human blastocoel
fluid. Sci Rep. 9(84)2019.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Basile MS, Fagone P, Mangano K, Mammana S,
Magro G, Salvatorelli L, Li Destri G, La Greca G, Nicoletti F,
Puleo S and Pesce A: KCNMA1 Expression is Downregulated in
Colorectal Cancer via Epigenetic Mechanisms. Cancers (Basel).
11pii. (E245)2019.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Falzone L, Scola L, Zanghì A, Biondi A, Di
Cataldo A, Libra M and Candido S: Integrated analysis of colorectal
cancer microRNA datasets: Identification of microRNAs associated
with tumor development. Aging (Albany NY). 10:1000–1014.
2018.PubMed/NCBI View Article : Google Scholar
|
|
56
|
McCubrey JA, Fitzgerald TL, Yang LV,
Lertpiriyapong K, Steelman LS, Abrams SL, Montalto G, Cervello M,
Neri LM, Cocco L, et al: Roles of GSK-3 and microRNAs on epithelial
mesenchymal transition and cancer stem cells. Oncotarget.
8:14221–14250. 2017.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Falzone L, Candido S, Salemi R, Basile MS,
Scalisi A, McCubrey JA, Torino F, Signorelli SS, Montella M and
Libra M: Computational identification of microRNAs associated to
both epithelial to mesenchymal transition and NGAL/MMP-9 pathways
in bladder cancer. Oncotarget. 7:72758–72766. 2016.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Hafsi S, Candido S, Maestro R, Falzone L,
Soua Z, Bonavida B, Spandidos DA and Libra M: Correlation between
the overexpression of Yin Yang 1 and the expression levels of
miRNAs in Burkitt's lymphoma: A computational study. Oncol Lett.
11:1021–1025. 2016.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Falzone L, Lupo G, Rosa GRM, Crimi S,
Anfuso CD, Salemi R, Rapisarda E, Libra M and Candido S:
Identification of Novel MicroRNAs and Their Diagnostic and
Prognostic Significance in Oral Cancer. Cancers (Basel). 11pii.
(E610)2019.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Falzone L, Salemi R, Travali S, Scalisi A,
McCubrey JA, Candido S and Libra M: MMP-9 overexpression is
associated with intragenic hypermethylation of MMP9 gene in
melanoma. Aging (Albany NY). 8:933–944. 2016.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Dy GK and Adjei AA: Understanding,
recognizing, and managing toxicities of targeted anticancer
therapies. CA Cancer J Clin. 63:249–279. 2013.PubMed/NCBI View Article : Google Scholar
|
|
62
|
McGranahan N and Swanton C: Biological and
therapeutic impact of intratumor heterogeneity in cancer evolution.
Cancer Cell. 27:15–26. 2015.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Thorsson V, Gibbs DL, Brown SD, Wolf D,
Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy
JA, et al: Cancer Genome Atlas Research Network: The Immune
Landscape of Cancer. Immunity. 48:812–830.e14. 2018.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Presti M, Mazzon E, Basile MS, Petralia
MC, Bramanti A, Colletti G, Bramanti P, Nicoletti F and Fagone P:
Overexpression of macrophage migration inhibitory factor and
functionally-related genes, D-DT, CD74, CD44, CXCR2 and CXCR4, in
glioblastoma. Oncol Lett. 16:2881–2886. 2018.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Mangano K, Mazzon E, Basile MS, Di Marco
R, Bramanti P, Mammana S, Petralia MC, Fagone P and Nicoletti F:
Pathogenic role for macrophage migration inhibitory factor in
glioblastoma and its targeting with specific inhibitors as novel
tailored therapeutic approach. Oncotarget. 9:17951–17970.
2018.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Basile MS, Mazzon E, Russo A, Mammana S,
Longo A, Bonfiglio V, Fallico M, Caltabiano R, Fagone P, Nicoletti
F, et al: Differential modulation and prognostic values of
immune-escape genes in uveal melanoma. PLoS One.
14(e0210276)2019.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Emens LA, Ascierto PA, Darcy PK, Demaria
S, Eggermont AMM, Redmond WL, Seliger B and Marincola FM: Cancer
immunotherapy: Opportunities and challenges in the rapidly evolving
clinical landscape. Eur J Cancer. 81:116–129. 2017.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Toh HC: Cancer immunotherapy-the end of
the beginning. Linchuang Zhongliuxue Zazhi. 7(12)2018.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Roy S and Trinchieri G: Microbiota: A key
orchestrator of cancer therapy. Nat Rev Cancer. 17:271–285.
2017.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Nayak RR and Turnbaugh PJ: Mirror, mirror
on the wall: Which microbiomes will help heal them all? BMC Med.
14(72)2016.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Fessler JL and Gajewski TF: The
Microbiota: A New Variable Impacting Cancer Treatment Outcomes.
Clin Cancer Res. 23:3229–3231. 2017.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Schwabe RF and Jobin C: The microbiome and
cancer. Nat Rev Cancer. 13:800–812. 2013.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Gopalakrishnan V, Helmink BA, Spencer CN,
Reuben A and Wargo JA: The Influence of the Gut Microbiome on
Cancer, Immunity, and Cancer Immunotherapy. Cancer Cell.
33:570–580. 2018.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Routy B, Le Chatelier E, Derosa L, Duong
CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C,
Roberti MP, et al: Gut microbiome influences efficacy of PD-1-based
immunotherapy against epithelial tumors. Science. 359:91–97.
2018.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Gopalakrishnan V, Spencer CN, Nezi L,
Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman
K, Wei SC, et al: Gut microbiome modulates response to anti-PD-1
immunotherapy in melanoma patients. Science. 359:97–103.
2018.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Matson V, Fessler J, Bao R, Chongsuwat T,
Zha Y, Alegre ML, Luke JJ and Gajewski TF: The commensal microbiome
is associated with anti-PD-1 efficacy in metastatic melanoma
patients. Science. 359:104–108. 2018.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Chen Q, Wang C, Chen G, Hu Q and Gu Z:
Delivery Strategies for Immune Checkpoint Blockade. Adv Healthc
Mater. 7(e1800424)2018.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Buchbinder EI and Desai A: CTLA-4 and PD-1
Pathways: Similarities, Differences, and Implications of Their
Inhibition. Am J Clin Oncol. 39:98–106. 2016.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Falzone L, Salomone S and Libra M:
Evolution of Cancer Pharmacological Treatments at the Turn of the
Third Millennium. Front Pharmacol. 9(1300)2018.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Mego M, Holec V, Drgona L, Hainova K,
Ciernikova S and Zajac V: Probiotic bacteria in cancer patients
undergoing chemotherapy and radiation therapy. Complement Ther Med.
21:712–723. 2013.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Maria-Aggeliki KS, Nikolaos KL, Kyrias GM
and Vassilis KE: The potential clinical impact of probiotic
treatment for the prevention and/or anti-inflammatory therapeutic
effect against radiation induced intestinal mucositis. A review.
Recent Pat Inflamm Allergy Drug Discov. 3:195–200. 2009. View Article : Google Scholar
|
|
82
|
Rondanelli M, Faliva MA, Perna S, Giacosa
A, Peroni G and Castellazzi AM: Using probiotics in clinical
practice: Where are we now? A review of existing meta-analyses. Gut
Microbes. 8:521–543. 2017.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Zitvogel L, Ma Y, Raoult D, Kroemer G and
Gajewski TF: The microbiome in cancer immunotherapy: Diagnostic
tools and therapeutic strategies. Science. 359:1366–1370.
2018.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Vanderhoof JA and Young R: Probiotics in
the United States. Clin Infect Dis. 46 (Suppl 2):S67–S72;
discussion S144-S151. 2008.PubMed/NCBI View
Article : Google Scholar
|
|
85
|
Redman MG, Ward EJ and Phillips RS: The
efficacy and safety of probiotics in people with cancer: A
systematic review. Ann Oncol. 25:1919–1929. 2014.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Peterson DE, Boers-Doets CB, Bensadoun RJ,
Herrstedt J and Committee EG: ESMO Guidelines Committee Management
of oral and gastrointestinal mucosal injury: ESMO Clinical Practice
Guidelines for diagnosis, treatment, and follow-up. Ann Oncol. 26
(Suppl 5):v139–v151. 2015. View Article : Google Scholar
|
|
87
|
Lalla RV, Bowen J, Barasch A, Elting L,
Epstein J, Keefe DM, McGuire DB, Migliorati C, Nicolatou-Galitis O,
Peterson DE, et al: Mucositis Guidelines Leadership Group of the
Multinational Association of Supportive Care in Cancer and
International Society of Oral Oncology (MASCC/ISOO): MASCC/ISOO
clinical practice guidelines for the management of mucositis
secondary to cancer therapy. Cancer. 120:1453–1461. 2014.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Gianotti L, Morelli L, Galbiati F,
Rocchetti S, Coppola S, Beneduce A, Gilardini C, Zonenschain D,
Nespoli A and Braga M: A randomized double-blind trial on
perioperative administration of probiotics in colorectal cancer
patients. World J Gastroenterol. 16:167–175. 2010.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Demers M, Dagnault A and Desjardins J: A
randomized double-blind controlled trial: Impact of probiotics on
diarrhea in patients treated with pelvic radiation. Clin Nutr.
33:761–767. 2014.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Mego M, Chovanec J, Vochyanova-Andrezalova
I, Konkolovsky P, Mikulova M, Reckova M, Miskovska V, Bystricky B,
Beniak J, Medvecova L, et al: Prevention of irinotecan induced
diarrhea by probiotics: A randomized double blind, placebo
controlled pilot study. Complement Ther Med. 23:356–362.
2015.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Theodoropoulos GE, Memos NA, Peitsidou K,
Karantanos T, Spyropoulos BG and Zografos G: Synbiotics and
gastrointestinal function-related quality of life after elective
colorectal cancer resection. Ann Gastroenterol. 29:56–62.
2016.PubMed/NCBI
|
|
92
|
Consoli ML, da Silva RS, Nicoli JR,
Bruña-Romero O, da Silva RG, de Vasconcelos Generoso S and Correia
MI: Randomized Clinical Trial: Impact of Oral Administration of
Saccharomyces boulardii on Gene Expression of Intestinal Cytokines
in Patients Undergoing Colon Resection. JPEN J Parenter Enteral
Nutr. 40:1114–1121. 2016.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Flesch AT, Tonial ST, Contu PC and Damin
DC: Perioperative synbiotics administration decreases postoperative
infections in patients with colorectal cancer: A randomized,
double-blind clinical trial. Rev Col Bras Cir. 44:567–573.
2017.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Goldin BR, Gualtieri LJ and Moore RP: The
effect of Lactobacillus GG on the initiation and promotion
of DMH-induced intestinal tumors in the rat. Nutr Cancer.
25:197–204. 1996.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Banna GL, Torino F, Marletta F, Santagati
M, Salemi R, Cannarozzo E, Falzone L, Ferraù F and Libra M:
Lactobacillus rhamnosus GG: An Overview to Explore the
Rationale of Its Use in Cancer. Front Pharmacol.
8(603)2017.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Lee CS, Ryan EJ and Doherty GA:
Gastro-intestinal toxicity of chemotherapeutics in colorectal
cancer: The role of inflammation. World J Gastroenterol.
20:3751–3761. 2014.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Khailova L, Baird CH, Rush AA, Barnes C
and Wischmeyer PE: Lactobacillus rhamnosus GG treatment
improves intestinal permeability and modulates inflammatory
response and homeostasis of spleen and colon in experimental model
of Pseudomonas aeruginosa pneumonia. Clin Nutr. 36:1549–1557.
2017.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Wang Y, Liu L, Moore DJ, Shen X, Peek RM,
Acra SA, Li H, Ren X, Polk DB and Yan F: An LGG-derived protein
promotes IgA production through upregulation of APRIL expression in
intestinal epithelial cells. Mucosal Immunol. 10:373–384.
2017.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Fong FLY, Kirjavainen PV and El-Nezami H:
Immunomodulation of Lactobacillus rhamnosus GG (LGG)-derived
soluble factors on antigen-presenting cells of healthy blood
donors. Sci Rep. 6(22845)2016.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Vivarelli S, Salemi R, Candido S, Falzone
L, Santagati M, Stefani S, Torino F, Banna GL, Tonini G and Libra
M: Gut Microbiota and Cancer: From Pathogenesis to Therapy. Cancers
(Basel). 11pii. (E38)2019.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Riehl TE, Alvarado D, Ee X, Zuckerman A,
Foster L, Kapoor V, Thotala D, Ciorba MA and Stenson WF: GG
protects the intestinal epithelium from radiation injury through
release of lipoteichoic acid, macrophage activation and the
migration of mesenchymal stem cells. Gut. 68:1003–1013.
2018.PubMed/NCBI View Article : Google Scholar
|
